These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23040902)

  • 1. Psychopharmacologic treatment for pediatric anxiety disorders.
    Peters TE; Connolly S
    Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):789-806. PubMed ID: 23040902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopharmacologic treatment of panic, generalized anxiety disorder, and social phobia.
    Roy-Byrne P; Wingerson D; Cowley D; Dager S
    Psychiatr Clin North Am; 1993 Dec; 16(4):719-35. PubMed ID: 8309809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beliefs about psychotropic medication and psychotherapy among primary care patients with anxiety disorders.
    Wagner AW; Bystritsky A; Russo JE; Craske MG; Sherbourne CD; Stein MB; Roy-Byrne PP
    Depress Anxiety; 2005; 21(3):99-105. PubMed ID: 15965996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacotherapy of anxiety disorders in children and adolescents.
    Kutcher SP; Reiter S; Gardner DM; Klein RG
    Psychiatr Clin North Am; 1992 Mar; 15(1):41-67. PubMed ID: 1549548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacologic treatment of anxiety disorders: a review of progress.
    Ravindran LN; Stein MB
    J Clin Psychiatry; 2010 Jul; 71(7):839-54. PubMed ID: 20667290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rages and refusals. Managing the many faces of adolescent anxiety.
    Garland EJ
    Can Fam Physician; 2001 May; 47():1023-30. PubMed ID: 11398717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric aspects of AIDS and psychopharmacologic management.
    Gilmer WS; Busch KA
    Psychiatr Med; 1991; 9(2):313-29. PubMed ID: 1857766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug therapies in anxiety disorders of children].
    Jalenques I; Coudert AJ
    Ann Pediatr (Paris); 1992 Jun; 39(6):339-46. PubMed ID: 1497282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopharmacologic treatment of anxiety disorders in adolescents and children.
    Popper CW
    J Clin Psychiatry; 1993 May; 54 Suppl():52-63. PubMed ID: 8099578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in the epidemiology and treatment of anxiety disorders.
    Pigott TA
    J Clin Psychiatry; 1999; 60 Suppl 18():4-15. PubMed ID: 10487250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric comorbidity and treatment response in patients with tuberous sclerosis complex.
    Chung TK; Lynch ER; Fiser CJ; Nelson DA; Agricola K; Tudor C; Franz DN; Krueger DA
    Ann Clin Psychiatry; 2011 Nov; 23(4):263-9. PubMed ID: 22073383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychopharmacologic treatment of pediatric anxiety disorders.
    Reinblatt SP; Walkup JT
    Child Adolesc Psychiatr Clin N Am; 2005 Oct; 14(4):877-908, x. PubMed ID: 16171707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possibility of the psychopharmacologic modification of behavior disorders. On the concept of an integrative therapy of neurotic disorders].
    Zapotoczky HG
    Psychother Psychosom Med Psychol; 1982 Nov; 32(6):199-203. PubMed ID: 7178404
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel treatment approaches for refractory anxiety disorders.
    Pollack MH; Otto MW; Roy-Byrne PP; Coplan JD; Rothbaum BO; Simon NM; Gorman JM
    Depress Anxiety; 2008; 25(6):467-76. PubMed ID: 17437259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of beliefs about psychotropic medication and psychotherapy: development of a measure for patients with anxiety disorders.
    Bystritsky A; Wagner AW; Russo JE; Stein MB; Sherbourne CD; Craske MG; Roy-Byrne PP
    Gen Hosp Psychiatry; 2005; 27(5):313-8. PubMed ID: 16168790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the effects of moderate alcohol intake on the treatment of anxiety and mood disorders.
    Castaneda R; Sussman N; Westreich L; Levy R; O'Malley M
    J Clin Psychiatry; 1996 May; 57(5):207-12. PubMed ID: 8626352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopharmacologic treatment of anxiety in the medically ill elderly patient: special considerations.
    Stoudemire A; Moran MG
    J Clin Psychiatry; 1993 May; 54 Suppl():27-33; discussion 34-6. PubMed ID: 8099576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of anxiety in the elderly.
    Markovitz PJ
    J Clin Psychiatry; 1993 May; 54 Suppl():64-8. PubMed ID: 8099579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychopharmacology in pediatric critical care.
    Stoddard FJ; Usher CT; Abrams AN
    Child Adolesc Psychiatr Clin N Am; 2006 Jul; 15(3):611-55. PubMed ID: 16797442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paroxetine treatment of mood and anxiety disorders in children and adolescents.
    Wagner KD
    Psychopharmacol Bull; 2003; 37 Suppl 1():167-75. PubMed ID: 14566209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.